{"result": "(\"entity\"<|>NADYA<|>ORGANIZATION<|>NADYA is a registry that collects data on patients receiving home parenteral nutrition (NPD) since 1992.)\n##\n(\"entity\"<|>OASIS<|>ORGANIZATION<|>OASIS was a registry in the USA that recorded patients with NPD in 1987 before changing its name to the National Registry of Enteral and Parenteral Nutrition.)\n##\n(\"entity\"<|>SUSTAIN<|>ORGANIZATION<|>Sustain is a system created in 2011 aimed at including 100% of incident and prevalent patients with NPD.)\n##\n(\"entity\"<|>BANS<|>ORGANIZATION<|>BANS is a British registry that published data on the prevalence of NPD in 2011.)\n##\n(\"entity\"<|>CANADA<|>GEO<|>Canada is a country that has its own data on NPD, reporting a prevalence of 13.3 cases/million in 2012.)\n##\n(\"entity\"<|>UNITED KINGDOM<|>GEO<|>The United Kingdom is a country that published its last NPD registry in 2011, showing a prevalence of 8.4 patients/million.)\n##\n(\"entity\"<|>EUROPE<|>GEO<|>Europe is a continent where the prevalence of NPD varied significantly in 1993, ranging from 0.3 to 12.2 patients/million.)\n##\n(\"entity\"<|>USA<|>GEO<|>The USA is a country where the OASIS registry recorded a total of 19,700 patients with NPD in 1987.)\n##\n(\"entity\"<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>EVENT<|>Home artificial nutrition (NAD) has significantly advanced the care of chronic patients, particularly oncological patients, allowing for improved nutritional status without hospitalization.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>EVENT<|>Home parenteral nutrition (NPD) is a treatment for patients who cannot meet their nutritional needs through natural foods.)\n##\n(\"relationship\"<|>NADYA<|>SUSTAIN<|>NADYA and Sustain are both registries related to the collection of data on patients receiving NPD, with Sustain being a newer system created to include all patients.<|>5)\n##\n(\"relationship\"<|>OASIS<|>NADYA<|>OASIS was a previous registry that collected data on NPD patients before NADYA took over the role of data collection.<|>5)\n##\n(\"relationship\"<|>BANS<|>EUROPE<|>BANS is a registry from the United Kingdom, which is part of Europe, that published data on NPD prevalence.<|>3)\n##\n(\"relationship\"<|>CANADA<|>EUROPE<|>Canada is a country that has its own data on NPD, contributing to the understanding of NPD prevalence in the broader European context.<|>3)\n##\n(\"relationship\"<|>USA<|>OASIS<|>The USA is the country where the OASIS registry was established to record patients with NPD.<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN ARTIFICIAL DOMICILIARIA<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>Home artificial nutrition (NAD) includes home parenteral nutrition (NPD) as a significant component of care for patients unable to meet their nutritional needs through natural means.<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ) Evolución de la nutrición parenteral domiciliaria (NPD) según el Registro NADYA\n\n| Año      | 1992 | 1994 | 1995 | 1996 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011-2012 | 2013 | 2014 |\n|----------|------|------|------|------|------|------|------|------|------|------|------|------|------|------|------|------------|------|------|\n| Pacientes NPD | 39   | 30   | 19   | 38   | 67   | 66   | 74   | 86   | 70   | 79   | 103  | 133  | 143  | 158  | 148  | 184        | 197  | 220  |\n\nFigura 1. Evolución del número de pacientes con NAD incluidos en el Registro NADYA.\n---\nTema 60. Nutrición artificial domiciliaria    943\n\nEn EEUU el registro OASIS recogió en 1987 un total de 19700 pacientes con NPD31. Posteriormente, este registro cambió su nombre a Registro Nacional de Nutrición Enteral y Parenteral, publicando sus datos de prevalencia entre 1989 y 1992 (238 pacientes/millón en población beneficiaria de Medicare y de 120 pacientes/millón en población general). Tras estos registros, en EEUU se interrumpió la recogida de datos, por resultar muy costoso su mantenimiento, y existe un vacío de datos hasta 2011, año en el que se crea el sistema Sustain, que pretende incluir al 100% de pacientes con NPD incidentes y prevalentes33. En su informe final de 2015 reportaron 1.642 pacientes incluidos 32 centros34.\n\nEn Europa, la prevalencia de NPD oscilaba en 1993 entre 0,3 y 12,2 pacientes/millón, con una incidencia de nuevos casos de 0,2 a 4,6/millón/año35. Esta gran disparidad entre Europa y EEUU puede justificarse por las diferencias en el sistema de financiación, en la preparación y la experiencia de los equipos que manejan la NPD, en la presión para acortar las estancias hospitalarias y en la organización de la atención domiciliaria o de la coordinación entre hospital y primaria.\n\nAlgunos países europeos o americanos también disponen de datos propios de NPD, como Canadá o Reino Unido. Así, el último registro británico BANS de 2011 publicó una prevalencia de NPD de 8,4 pacientes/millón12, y Canadá, según su informe de 2012, una prevalencia algo superior (13,3 casos/millón)36.\n\nEn nuestro país, el registro NADYA-SENPE recoge los pacientes con NPD desde el año 1992, aunque hay algún período sin información (1993 y 1997-1999). A lo largo de estos años el número de pacientes incluidos se ha multiplicado, aunque a gran distancia de la casuística de otros países. El último registro disponible, correspondiente a 2014, reportó 220 pacientes con 229 episodios de NPD (211 adultos), lo que representa una tasa de 4,73 pacientes/millón/año. La indicación más frecuente fue el síndrome de intestino corto (32,2%), seguido de la obstrucción intestinal (25,6%). Los catéteres tunelizados se emplearon en el 46,3% de los pacientes y la NPD fue utilizada como único aporte en el 52,1%. La duración de la NPD ascendió a 612 días de mediana y se finalizó durante el año de estudio en 68 casos (en un 48,5% por fallecimiento del enfermo y en un 33,8% por paso a la vía oral). La figura 1B ilustra el aumento de pacientes incluidos entre 1992 y 201415-17, 37-48.\n\n## 4. Requisitos\n\nLa nutrición artificial domiciliaria (NAD), tanto enteral como parenteral, ha supuesto un gran avance de cara a los cuidados de pacientes crónicos, en muchas ocasiones pacientes oncológicos. Ha permitido mejorar el estado nutricional sin la necesidad de permanecer ingresado. La instauración de la NAD requiere una valoración del estado y pronóstico del paciente, de su entorno familiar y aportar una educación adecuada de cara al manejo de sondas o catéteres en personal no sanitario. La indicación de NAD debe basarse en un programa estructurado que incluya:\n\n1. Adecuada identificación y selección de los pacientes tributarios de este tratamiento (tabla 4).\n\nLos candidatos serán aquellos pacientes en situación clínica estable, que no puedan cubrir sus requerimientos nutricionales con alimentos naturales. Asimismo, es imprescindible la aceptación por parte de la familia de este tipo de soporte, disponer\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}